ZUG, Switzerland, Nov. 21,
2024 /PRNewswire/ -- SHL Medical, a world leader in
self-injection solutions, today announced plans to establish SHL
Advantec – a dynamic sub-group dedicated to providing tooling and
automation solutions to the healthcare sector and other
industries.
The establishment of SHL Advantec is part of SHL Medical's
ambitious expansion strategy and ongoing commitment to improving
the lives of patients. The strategic move will allow SHL Medical to
further focus on growing its business in self-injection devices
while SHL Advantec provides advanced manufacturing and packaging
technologies for medical devices and other healthcare products.
SHL Medical's existing tooling and automation operations will be
integrated into SHL Advantec, bringing their range of technologies,
services, and equipment portfolio to the new business. Together
with SHL Medical's recent strategic acquisitions – Swiss-based LCA
Automation and SMC Mould Innovation and US-based Superior Tooling –
SHL Advantec will form a global operations network spanning three
continents to deliver faster support and shorter supply chain
services to SHL Advantec's diverse customer base. Leveraging its
experience in medical devices and other industries, SHL Advantec
will focus on helping its customers advance production quality and
resilience while continuing to support SHL Medical's growth in
autoinjector manufacturing.
"SHL Medical has always taken pride in being a true end-to-end
solutions provider of autoinjector development and manufacturing,
and part of that pride is built on our much-trusted tooling and
automation solutions, which had been the backbone of SHL Medical's
ability to scale up production for our customers," said
Ulrich Faessler, CEO of SHL Medical.
"As we prepare to pioneer the next era of innovative self-injection
solutions, the strategic move will give SHL Medical and SHL
Advantec the opportunity to maximize our strengths, both separately
and collectively, to create more long-term value to our customers,
their patients, and the entire pharmaceutical and healthcare value
chain."
SHL Advantec will be headquartered in Zug, Switzerland and will begin operations with
over 600 dedicated employees across its offices and production
sites in Switzerland, China, Taiwan, Mexico, and the US.
About SHL Medical
As a pioneering leader in self-injection solutions, SHL Medical
is the partner of choice for many leading pharma and biotech
companies. Driven by our company purpose – Enabling Patients'
Independence – we offer patient-centric solutions for the design,
development, and manufacturing of autoinjectors, pen injectors, as
well as innovative specialty delivery systems for large-volume and
high-viscosity formulations. We also offer final assembly,
labeling, and packaging solutions for our drug delivery
systems.
In response to the rising trend in home therapy, SHL Medical has
increased developmental work in the digital healthcare sector to
help improve the drug delivery ecosystem.
Located across Switzerland,
Taiwan, Sweden, and the US, our global team of
experts collaborate seamlessly as one team in utilizing our
comprehensive in-house manufacturing capabilities. Our solutions
offer customization and optimization for each project
while proactively weaving sustainability-driven measures into our
designs and processes to contribute to a cleaner earth.
For additional information, visit www.shl-medical.com
Media contact
Carl Gillblad
Communications and Marketing
info@shl-medical.com
Customer inquiries
Gilbert Fluetsch
Commercial and Technical Services
info-advantec@shl-medical.com
Supplier relations
Joel Scheidegger
Supply Chain Management
procurement.advantec@shl-medical.com
Photo -
https://mma.prnewswire.com/media/2563251/SHL_Medical.jpg
Photo -
https://mma.prnewswire.com/media/2563252/SHL_Medical_SHL_Advantec.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/shl-medical-announces-plans-to-establish-shl-advantec-302311858.html